Mexico has already seen a black market or fake molnupiravir for sale on Friday, just a week after authorities approved a drug to treat people at risk for severe COVID-19. He said he was.
The actual drug is manufactured by the US pharmaceutical company Merck. However, Mexican health regulators have found a version labeled Molnupiravir for sale by a range of companies such as “Merit,” “Morazu,” and “Ajista.”
Authorities said on Friday that they had no record of permission to import or sell their drugs and considered them healthy. Danger..
The Federal Health Protection Commission said that because molnupiravir is only approved for the use of prescription drugs, “products advertised as molnupiravir on the market should be considered a health risk because of their questionable origin.” It states.
Last week, the Mexican government approved Merck’s Molnupiravir for use with COVID-19 in adults who are “at high risk of complications.”On Friday, the agency took Paxlovid, the second pill from Pfizer. Adult patient “There is a risk of complications.”
Mexico has long been plagued by counterfeit medicines, corruption within regulatory agencies, and a tendency for self-medication due to national inadequacies. health Care infrastructure.
In this country, apparently due to Omicron variants, coronavirus cases surged by more than 200% last week, facing a lack of testing and consumers. Black market..
Mexico has rarely tested, so only about 300,000 deaths from COVID-19 have been confirmed in the test, but a government review of death certificates shows that the actual number of deaths is about 460,000. ..
© 2022 AP communication. all rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Quote: In Mexico, a week after the drug was approved (January 15, 2022), fake molnupiravir was found at https://medicalxpress.com/news/2022-01-mexico-fake-molnupiravir-week-drug. Obtained from html.
This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. Content is provided for informational purposes only.
Mexico sees fake molnupiravir, 1 week after drug approved Source link Mexico sees fake molnupiravir, 1 week after drug approved